Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine mouthwash versus intravenous esketamine for chemotherapy/radiotherapy-induced oral mucositis pain
2025-522545-22-00Phase 2Authorised
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of esketamine in stomatitis, sponsored by Amsterdam University Medical Center. Planned start Mar 2026; status: authorised.
02
Drugs
esketamine
03
Conditions
stomatitis
Beyond the preview
Go deeper on 2025-522545-22-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522545-22-00.